Latest News
Hologic to Acquire Medical Device Provider Bolder Surgical for USD 160m
Friday 15 October 2021

Massachusetts. US-based medical technology company Hologic, Inc. (NASDAQ: HOLX) has agreed to acquire Colorado-based vessel sealing surgical devices provider Bolder Surgical, for approximately USD 160m, to expand surgical franchise, the company said.

The acquisition is expected to close by the end of calendar 2021, subject to antitrust clearance and other customary closing conditions.

This acquisition will broaden Hologic's growing Surgical portfolio by adding Bolder's differentiated advanced vessel sealing and dissection tools that are used in laparoscopic procedures.

The transaction adds laparoscopic vessel sealing, dividing and dissecting devices to the Hologic portfolio and also will enable Hologic to expand the use of Bolder's devices to OB/GYN specialists.

The complementary acquisition of Bolder Surgical will add to Hologic's surgical product line, which includes the NovaSure endometrial ablation system for the treatment of abnormal uterine bleeding, the MyoSure tissue removal devices for the treatment of intrauterine fibroids and polyps, the Acessa laparoscopic radiofrequency ablation system for the treatment of fibroids, and the Fluent fluid management system for streamlining hysteroscopic procedures.

Hologic, Inc. is a medical technology company primarily focussed on improving women's health and well-being through early detection and treatment.

Bolder Surgical, Inc. is a commercial-stage developer and manufacturer of advanced energy vessel sealing and dissection tools, offering devices to surgical gynecologists in both laparoscopic and open procedures.
Date Published: 15/10/2021